Search research articles
Contact Us
Filters
Showing results (191-200 of 456) with videos related to
Page
of 46
Sort By:
The Kaohsiung Journal of Medical Sciences
|
November 5, 2020
Real-world effectiveness of direct-acting antiviral agents for chronic hepatitis C patients with genotype-2 infection after completed treatment
Tzu-Sheng Cheng, Po-Cheng Liang, Chung-Feng Huang, et al.
The Kaohsiung Journal of Medical Sciences
|
March 3, 2020
Primary culture of aspiration residual specimens improves the diagnostic accuracy between hepatocellular carcinoma and benign nodules
Zu-Yau Lin, Jing-Houng Wang, Ming-Lun Yeh, et al.
Hepatology International
|
July 24, 2015
APASL consensus statements and management algorithms for hepatitis C virus infection
Masao Omata, Tatsuo Kanda, Ming-Lung Yu, et al.
Plos One
|
January 4, 2013
Revisiting the stopping rule for hepatitis C genotype 1 patients treated with peginterferon plus ribavirin
Ming-Lung Yu, Chen-Hua Liu, Chung-Feng Huang, et al.
Journal of Gastroenterology and Hepatology
|
July 5, 2014
Randomized, controlled pharmacokinetic and pharmacodynamic evaluation of albinterferon in patients with chronic hepatitis B infection
Richard A Colvin, Tawesak Tanwandee, Teerha Piratvisuth, et al.
Journal of Hepatology
|
August 26, 2014
Telbivudine plus pegylated interferon alfa-2a in a randomized study in chronic hepatitis B is associated with an unexpected high rate of peripheral neuropathy
Patrick Marcellin, Karsten Wursthorn, Heiner Wedemeyer, et al.
Journal of the Chinese Medical Association : JCMA
|
April 5, 2019
Elevated interleukin-4 levels predicted advanced fibrosis in chronic hepatitis C
Batbold Batsaikhan, Ming-Ying Lu, Ming-Lun Yeh, et al.
Gastroenterology
|
December 17, 2009
Farglitazar lacks antifibrotic activity in patients with chronic hepatitis C infection
John McHutchison, Zachary Goodman, Keyur Patel, et al.
Journal of Gastroenterology and Hepatology
|
November 28, 2002
Clinical characteristics and distribution of genotypes of TT virus infection in a hepatitis C virus-hyperendemic township of a hepatitis B virus-endemic country (Taiwan)
Chia-Yen Dai, Ming-Lung Yu, Cheng Hou, et al.
Clinical Therapeutics
|
February 14, 2007
Early mortality in Taiwanese lamivudine-treated patients with chronic hepatitis B-related decompensation: evaluation of the model for end-stage liver disease and index scoring systems as prognostic predictors
Chia-Yen Dai, Wan-Long Chuang, Nai-Jen Hou, et al.
Page
of 46
Search research articles
Search
Showing results (191-200 of 456) with videos related to
Sort By:
Page
of 46
The Kaohsiung Journal of Medical Sciences
|
November 5, 2020
Real-world effectiveness of direct-acting antiviral agents for chronic hepatitis C patients with genotype-2 infection after completed treatment
Tzu-Sheng Cheng, Po-Cheng Liang, Chung-Feng Huang, et al.
The Kaohsiung Journal of Medical Sciences
|
March 3, 2020
Primary culture of aspiration residual specimens improves the diagnostic accuracy between hepatocellular carcinoma and benign nodules
Zu-Yau Lin, Jing-Houng Wang, Ming-Lun Yeh, et al.
Hepatology International
|
July 24, 2015
APASL consensus statements and management algorithms for hepatitis C virus infection
Masao Omata, Tatsuo Kanda, Ming-Lung Yu, et al.
Plos One
|
January 4, 2013
Revisiting the stopping rule for hepatitis C genotype 1 patients treated with peginterferon plus ribavirin
Ming-Lung Yu, Chen-Hua Liu, Chung-Feng Huang, et al.
Journal of Gastroenterology and Hepatology
|
July 5, 2014
Randomized, controlled pharmacokinetic and pharmacodynamic evaluation of albinterferon in patients with chronic hepatitis B infection
Richard A Colvin, Tawesak Tanwandee, Teerha Piratvisuth, et al.
Journal of Hepatology
|
August 26, 2014
Telbivudine plus pegylated interferon alfa-2a in a randomized study in chronic hepatitis B is associated with an unexpected high rate of peripheral neuropathy
Patrick Marcellin, Karsten Wursthorn, Heiner Wedemeyer, et al.
Journal of the Chinese Medical Association : JCMA
|
April 5, 2019
Elevated interleukin-4 levels predicted advanced fibrosis in chronic hepatitis C
Batbold Batsaikhan, Ming-Ying Lu, Ming-Lun Yeh, et al.
Gastroenterology
|
December 17, 2009
Farglitazar lacks antifibrotic activity in patients with chronic hepatitis C infection
John McHutchison, Zachary Goodman, Keyur Patel, et al.
Journal of Gastroenterology and Hepatology
|
November 28, 2002
Clinical characteristics and distribution of genotypes of TT virus infection in a hepatitis C virus-hyperendemic township of a hepatitis B virus-endemic country (Taiwan)
Chia-Yen Dai, Ming-Lung Yu, Cheng Hou, et al.
Clinical Therapeutics
|
February 14, 2007
Early mortality in Taiwanese lamivudine-treated patients with chronic hepatitis B-related decompensation: evaluation of the model for end-stage liver disease and index scoring systems as prognostic predictors
Chia-Yen Dai, Wan-Long Chuang, Nai-Jen Hou, et al.
Page
of 46